OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

SARS-CoV-2 down-regulates ACE2 through lysosomal degradation
Yi Lu, Qingwei Zhu, Douglas Fox, et al.
Molecular Biology of the Cell (2022) Vol. 33, Iss. 14
Open Access | Times Cited: 43

Showing 1-25 of 43 citing articles:

The relationship between gut microbiota and COVID-19 progression: new insights into immunopathogenesis and treatment
Man Wang, Yuan Zhang, Chunmei Li, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 29

ACE2 in chronic disease and COVID-19: gene regulation and post-translational modification
Chia-Wen Wang, Huai‐Chia Chuang, Tse‐Hua Tan
Journal of Biomedical Science (2023) Vol. 30, Iss. 1
Open Access | Times Cited: 17

Type 1 diabetes: A new vision of the disease based on endotypes
Craig Sinclair Weston, Bernhard O. Boehm, Paolo Pozzilli
Diabetes/Metabolism Research and Reviews (2024) Vol. 40, Iss. 2
Open Access | Times Cited: 8

SARS-CoV-2 infection and its effects on the endocrine system
Charlotte Steenblock, Nicole Toepfner, Felix Beuschlein, et al.
Best Practice & Research Clinical Endocrinology & Metabolism (2023) Vol. 37, Iss. 4, pp. 101761-101761
Open Access | Times Cited: 16

The Role of Furin in the Pathogenesis of COVID-19-Associated Neurological Disorders
Gunel Ayyubova, Sergiy G. Gychka, Sofia I. Nikolaienko, et al.
Life (2024) Vol. 14, Iss. 2, pp. 279-279
Open Access | Times Cited: 5

Characterization of SARS-CoV-2 replication in human H1299/ACE2 cells: A versatile and practical infection model for antiviral research and beyond
Clarisse Salgado‐Benvindo, Ali Taş, Jessika C. Zevenhoven-Dobbe, et al.
Antiviral Research (2024) Vol. 227, pp. 105903-105903
Open Access | Times Cited: 4

The prognostic role of cardiac and inflammatory biomarkers in extubation failure in patients with COVID-19 acute respiratory distress syndrome
Carline N. L. Groenland, Adinde H. Siemers, Eric A. Dubois, et al.
Annals of Intensive Care (2025) Vol. 15, Iss. 1
Open Access

Modulation of RAAS receptors and miRNAs in COVID-19: implications for disease severity, immune response, and potential therapeutic targets
Thais Freitas Barreto Fernandes, José Henrique Pilotto, Priscila Alves Cezar, et al.
BMC Infectious Diseases (2025) Vol. 25, Iss. 1
Open Access

ACE2 and TMPRSS2 gene expression is reduced acutely in SARS-CoV-2 patients but returns to normal with recovery
Vivien Chen, Joshua K. Tay, Rijan Gurung, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access

The Renin–Angiotensin System (RAS) in COVID-19 Disease: Where We Are 3 Years after the Beginning of the Pandemic
Marco Prato, Natalia Tiberti, Cristina Mazzi, et al.
Microorganisms (2024) Vol. 12, Iss. 3, pp. 583-583
Open Access | Times Cited: 3

Mapping ACE2 and TMPRSS2 co-expression in human brain tissue: implications for SARS-CoV-2 neurological manifestations
Tulika Gupta, Munish Kumar, Ujjwal Jit Kaur, et al.
Journal of NeuroVirology (2024) Vol. 30, Iss. 3, pp. 316-326
Closed Access | Times Cited: 3

FGF7 enhances the expression of ACE2 in human islet organoids aggravating SARS-CoV-2 infection
Hao Meng, Zhiying Liao, Yanting Ji, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 3

Microbiome dysbiosis in SARS-CoV-2 infection: implication for pathophysiology and management strategies of COVID-19
Shukur Wasman Smail, Niaz Albarzinji, Rebaz Hamza Salih, et al.
Frontiers in Cellular and Infection Microbiology (2025) Vol. 15
Open Access

Differential Ability of Spike Protein of SARS-CoV-2 Variants to Downregulate ACE2
Yosuke Maeda, Mako Toyoda, Takeo Kuwata, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 1353-1353
Open Access | Times Cited: 3

USP2 inhibition prevents infection with ACE2-dependent coronaviruses in vitro and is protective against SARS-CoV-2 in mice
Fabin Dang, Lei Bai, Jiazhen Dong, et al.
Science Translational Medicine (2023) Vol. 15, Iss. 725
Closed Access | Times Cited: 7

CD81 suppresses NF-κB signaling and is downregulated in hepatitis C virus expressing cells
Maximilian Bunz, Mona Eisele, Dan Hu, et al.
Frontiers in Cellular and Infection Microbiology (2024) Vol. 14
Open Access | Times Cited: 2

Multifaceted role of SARS-CoV-2 structural proteins in lung injury
Guoping Zheng, Guanguan Qiu, Huifeng Qian, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2

Modulations of Homeostatic ACE2, CD147, GRP78 Pathways Correlate with Vascular and Endothelial Performance Markers during Pulmonary SARS-CoV-2 Infection
Annuurun Nisa, Ranjeet Kumar, Santhamani Ramasamy, et al.
Cells (2024) Vol. 13, Iss. 5, pp. 432-432
Open Access | Times Cited: 2

The basis of complications in the context of SARS-CoV-2 infection: Pathological activation of ADAM17
Shenghai Jiang, Hao Yang, Zhong‐Ming Sun, et al.
Biochemical and Biophysical Research Communications (2023) Vol. 679, pp. 37-46
Closed Access | Times Cited: 4

The Role of Furin on the Pathogenesis of COVID-19 Associated Neurological Disorders
Gunel Ayyubova, Sergiy G. Gychka, Sofia I. Nikolaienko, et al.
(2024)
Open Access | Times Cited: 1

Angiotensin-Converting Enzyme 2 Posttranslational Modifications and Implications for Hypertension and SARS-CoV-2: 2023 Lewis K. Dahl Memorial Lecture
Mona Elgazzaz, Catalin M. Filipeanu, Eric Lazartigues
Hypertension (2024) Vol. 81, Iss. 7, pp. 1438-1449
Closed Access | Times Cited: 1

Safety and Feasibility of Third-Party Cytotoxic T Lymphocytes for High-Risk Patients with Covid-19
Dolores Grosso, John L. Wagner, Allyson O’Connor, et al.
Blood Advances (2024) Vol. 8, Iss. 15, pp. 4113-4124
Open Access | Times Cited: 1

Page 1 - Next Page

Scroll to top